The present invention discloses an in situ method of screening a compound for pharmacological activity comprising the steps of detecting an initial pattern of neural activity in brain tissue, adding the compound to the brain tissue and detecting a resulting pattern of neural activity, and observing the pharmacological activity of the compound on neural activity by comparing the initial pattern of intracellular neural activity with the resulting pattern of neural activity.
Detection of neural activity